» Articles » PMID: 26753808

The Head Injury Transportation Straight to Neurosurgery (HITS-NS) Randomised Trial: a Feasibility Study

Abstract

Background: Reconfiguration of trauma services, with direct transport of traumatic brain injury (TBI) patients to neuroscience centres (NCs), bypassing non-specialist acute hospitals (NSAHs), could potentially improve outcomes. However, delays in stabilisation of airway, breathing and circulation (ABC) and the difficulties in reliably identifying TBI at scene may make this practice deleterious compared with selective secondary transfer from nearest NSAH to NC. National Institute for Health and Care Excellence guidance and systematic reviews suggested equipoise and poor-quality evidence - with regard to 'early neurosurgery' in this cohort - which we sought to address.

Methods: Pilot cluster randomised controlled trial of bypass to NC conducted in two ambulance services with the ambulance station (n = 74) as unit of cluster [Lancashire/Cumbria in the North West Ambulance Service (NWAS) and the North East Ambulance Service (NEAS)]. Adult patients with signs of isolated TBI [Glasgow Coma Scale (GCS) score of < 13 in NWAS, GCS score of < 14 in NEAS] and stable ABC, injured nearest to a NSAH were transported either to that hospital (control clusters) or bypassed to the nearest NC (intervention clusters).

Primary Outcomes: recruitment rate, protocol compliance, selection bias as a result of non-compliance, accuracy of paramedic TBI identification (overtriage of study inclusion criteria) and pathway acceptability to patients, families and staff. 'Open-label' secondary outcomes: 30-day mortality, 6-month Extended Glasgow Outcome Scale (GOSE) and European Quality of Life-5 Dimensions.

Results: Overall, 56 clusters recruited 293 (169 intervention, 124 control) patients in 12 months, demonstrating cluster randomised pre-hospital trials as viable for heath service evaluations. Overall compliance was 62%, but 90% was achieved in the control arm and when face-to-face paramedic training was possible. Non-compliance appeared to be driven by proximity of the nearest hospital and perceptions of injury severity and so occurred more frequently in the intervention arm, in which the perceived time to the NC was greater and severity of injury was lower. Fewer than 25% of recruited patients had TBI on computed tomography scan (n = 70), with 7% (n = 20) requiring neurosurgery (craniotomy, craniectomy or intracranial pressure monitoring) but a further 18 requiring admission to an intensive care unit. An intention-to-treat analysis revealed the two trial arms to be equivalent in terms of age, GCS and severity of injury. No significant 30-day mortality differences were found (8.8% vs. 9.1/%; p > 0.05) in the 273 (159/113) patients with data available. There were no apparent differences in staff and patient preferences for either pathway, with satisfaction high with both. Very low responses to invitations to consent for follow-up in the large number of mild head injury-enrolled patients meant that only 20% of patients had 6-month outcomes. The trial-based economic evaluation could not focus on early neurosurgery because of these low numbers but instead investigated the comparative cost-effectiveness of bypass compared with selective secondary transfer for eligible patients at the scene of injury.

Conclusions: Current NHS England practice of bypassing patients with suspected TBI to neuroscience centres gives overtriage ratios of 13 : 1 for neurosurgery and 4 : 1 for TBI. This important finding makes studying the impact of bypass to facilitate early neurosurgery not plausible using this study design. Future research should explore an efficient comparative effectiveness design for evaluating 'early neurosurgery through bypass' and address the challenge of reliable TBI diagnosis at the scene of injury.

Trial Registration: Current Controlled Trials ISRCTN68087745.

Funding: This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 20, No. 1. See the NIHR Journals Library website for further project information.

Citing Articles

Patients suffering traumatic brain injury: patient characteristics, prehospital triage, primary referral and mortality - A population-based follow-up study.

Seidenfaden S, Pedersen C, Juul N, Kirkegaard H, Botker M Scand J Trauma Resusc Emerg Med. 2024; 32(1):58.

PMID: 38898534 PMC: 11186223. DOI: 10.1186/s13049-024-01229-7.


A cost-effectiveness and value of information analysis to inform future research of tranexamic acid for older adults experiencing mild traumatic brain injury.

Williams J, Ker K, Roberts I, Shakur-Still H, Miners A Trials. 2022; 23(1):370.

PMID: 35505387 PMC: 9066715. DOI: 10.1186/s13063-022-06244-6.


Primary versus early secondary referral to a specialized neurotrauma center in patients with moderate/severe traumatic brain injury: a CENTER TBI study.

Sewalt C, Gravesteijn B, Menon D, Lingsma H, Maas A, Stocchetti N Scand J Trauma Resusc Emerg Med. 2021; 29(1):113.

PMID: 34348784 PMC: 8340517. DOI: 10.1186/s13049-021-00930-1.


Randomised controlled trials in pre-hospital trauma: a systematic mapping review.

Bjorklund M, Cruickshank M, Lendrum R, Gillies K Scand J Trauma Resusc Emerg Med. 2021; 29(1):65.

PMID: 34001219 PMC: 8127177. DOI: 10.1186/s13049-021-00880-8.


Tranexamic acid to reduce head injury death in people with traumatic brain injury: the CRASH-3 international RCT.

Roberts I, Shakur-Still H, Aeron-Thomas A, Beaumont D, Belli A, Brenner A Health Technol Assess. 2021; 25(26):1-76.

PMID: 33928903 PMC: 8107835. DOI: 10.3310/hta25260.